Farnesoid X receptor ‐ a molecular predictor of weight loss after vertical sleeve gastrectomy?

To determine the expression of the bile acid receptor, farnesoid X (FXR), in human gastric mucosa and investigate correlations between expression and body‐mass index (BMI) and in patients with obesity, with changes in weight and BMI following vertical sleeve gastrectomy (VSG)